PYCR2

pyrroline-5-carboxylate reductase 2, the group of MicroRNA protein coding host genes

Basic information

Region (hg38): 1:225919877-225924340

Links

ENSG00000143811 ∙ NCBI:29920 ∙ OMIM:616406 ∙ HGNC:30262 ∙ Uniprot:Q96C36 ∙ AlphaFold ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Phenotypes

GenCC

Source: genCC

• autosomal recessive primary microcephaly (Supportive), mode of inheritance: AR
• hypomyelinating leukodystrophy 10 (Definitive), mode of inheritance: AR
• hypomyelinating leukodystrophy 10 (Strong), mode of inheritance: AR
• hypomyelinating leukodystrophy 10 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

Condition	Inheritance	Intervention Categories	Intervention/Rationale	Manifestation Categories	References
Leukodystrophy, hypomyelinating 10	AR	General	Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing	Craniofacial; Musculoskeletal; Neurologic	25865492

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PYCR2 gene.

• not_provided (97 variants)
• Hypomyelinating_leukodystrophy_10 (37 variants)
• Inborn_genetic_diseases (32 variants)
• not_specified (8 variants)
• Leukodystrophy (2 variants)
• Metachromatic_leukodystrophy (1 variants)
• PYCR2-related_disorder (1 variants)
• Microcephaly (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PYCR2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000013328.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Effect	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous			1	30	1	32
missense	2	14	56	1	1	74
nonsense	3	2	1			6
start loss			2			2
frameshift	3	6				9
splice donor/acceptor (+/-2bp)	2	5				7
Total	10	27	60	31	2

Highest pathogenic variant AF is 0.000042750136

GnomAD

Source: gnomAD

Gene	Type	Bio Type	Transcript	Coding Exons	Length
PYCR2	protein_coding	protein_coding	ENST00000343818	7	4401

pLI Probability LOF Intolerant	pRec Probability LOF Recessive	Individuals with no LOFs	Individuals with Homozygous LOFs	Individuals with Heterozygous LOFs	Defined	p
0.00000207	0.476	125720	0	28	125748	0.000111

	Z-Score	Observed	Expected	Observed/Expected	Mutation Rate	Total Possible in Transcript
Missense	0.948	156	193	0.808	0.0000109	2053
Missense in Polyphen		34	61.079	0.55665		639
Synonymous	-0.520	92	85.9	1.07	0.00000542	691
Loss of Function	0.685	10	12.6	0.792	7.21e-7	135

LoF frequencies by population

Ethnicity	Sum of pLOFs	p
African & African-American	0.000729	0.000728
Ashkenazi Jewish	0.00	0.00
East Asian	0.0000544	0.0000544
Finnish	0.000139	0.000139
European (Non-Finnish)	0.0000619	0.0000615
Middle Eastern	0.0000544	0.0000544
South Asian	0.0000653	0.0000653
Other	0.00	0.00

dbNSFP

Source: dbNSFP

• Function: FUNCTION: Housekeeping enzyme that catalyzes the last step in proline biosynthesis. In some cell types, such as erythrocytes, its primary function may be the generation of NADP(+). Can utilize both NAD and NADP. Has higher affinity for NADP, but higher catalytic efficiency with NADH (PubMed:2722838, PubMed:6894153). Involved in cellular response to oxidative stress (PubMed:25865492). {ECO:0000269|PubMed:25865492, ECO:0000269|PubMed:2722838, ECO:0000269|PubMed:6894153}.
• Pathway: Arginine and proline metabolism - Homo sapiens (human);Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Prolinemia Type II;Prolidase Deficiency (PD);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);Metabolism of amino acids and derivatives;Metabolism;proline biosynthesis;Amino acid synthesis and interconversion (transamination) (Consensus)

Recessive Scores

• pRec: 0.162

Intolerance Scores

• loftool: 0.338
• rvis_EVS: -0.71
• rvis_percentile_EVS: 14.4

Haploinsufficiency Scores

• pHI: 0.201
• hipred: N
• hipred_score: 0.146
• ghis: 0.618

Essentials

• essential_gene_CRISPR: N
• essential_gene_CRISPR2: N
• essential_gene_gene_trap: N
• gene_indispensability_pred: E
• gene_indispensability_score: 0.969

Gene Damage Prediction

	All	Recessive	Dominant
Mendelian	Medium	Medium	Medium
Primary Immunodeficiency	Medium	Medium	Medium
Cancer	Medium	Medium	Medium

Mouse Genome Informatics

• Gene name: Pycr2
• Phenotype: immune system phenotype; hematopoietic system phenotype

Gene ontology

• Biological process: proline biosynthetic process;cellular amino acid biosynthetic process;cellular response to oxidative stress;oxidation-reduction process;L-proline biosynthetic process
• Cellular component: mitochondrion;mitochondrial matrix
• Molecular function: pyrroline-5-carboxylate reductase activity;protein binding